Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02179060 : Prehospital Resuscitation Intranasal Cooling Effects Seen in MRI of the Brain After Cardiac Arrest
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

1. Ventricular fibrillation or non-perfusive ventricular tachycardia as initial cardiac
rhythm.

2. The 1st attempt at resuscitation by emergency medical personnel must appear within 15
minutes after the collapse.

3. The cause for collapse should be considered primary as cardiogenic and the return of
spontaneous circulation (ROSC) should have been gained in 45 minutes after the
collapse.

4. Patient should be still unconscious in the emergency room.

5. Age: 18 - 80 years

6. Obtained consent after arrival to the hospital, and before MRI scan.

Exclusion Criteria:

7. Hypothermia (< 30°C core temperature)

8. Arrival of EMS after 15 minutes from collapse

9. Unconsciousness before cardiac arrest (cerebral trauma, spontaneous cerebral
haemorrhrages, intoxications etc.)

10. Terminal phase of a chronic disease, or known limitations in therapy and Do Not
Resuscitate-order or known pre-arrest Cerebral Performance Category 3 or 4

11. Factors making participation in follow-up unlikely

12. Factors making the RhinoChill cooling contraindicated: patients with known
contraindications to hypothermia (Raynaud's disease, Cryoglobulinemia, Sickle Cell
disease), have specific temperature-sensitive pathologies (e.g., serum cold
agglutinins, Buerger's disease), intranasal obstruction, or known skull base
fracture.

13. Pregnancy

14. Coagulopathy

15. Response to verbal commands after the return of spontaneous circulation (ROSC)

16. Systolic arterial pressure < 80 mmHg or mean arterial pressure < 60 mmHg for over 30
min period after ROSC

17. Evidence of hypoxemia (arterial oxygen saturation < 85%) for > 15 minutes after ROSC
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02179060      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740